Volume 34, Issue 4, December 2023

Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(4):454-59
Late Onset Systemic Lupus Erythematosus - Clinical and Autoantibody Profile and its Comparison with Young Onset Systemic Lupus Erythematosus
Authors Information

1Department of Rheumatology, SKIMS Soura Srinagar, India

2Department of Immunology and Molecular Medicine, SKIMS Soura Srinagar, India

3Deenanath Mangeshkar Hospital, Sassoon Gen Hospital Pune, India

4Kd Hospital, Ahmedabad Gujrat, India

5Synergy Rheumatology and Arthritis Clinic, India

6Fortis Hospital Gurgaon, India

7Moolchand Hospital Delhi, India

8Medanta-The Medicity Gurgaon, India

MA Bindroo, S Bajad, N Mendiratta, NV Negalur, D Raval, G Ekbote, N Majid


Objectives: The aim of the study was to determine the clinical features & autoantibody profile of patients having late onset Systemic Lupus Erythematosus (SLE) and to compare with young onset SLE due to its scarce data from India. Methods: All patients who fulfilled the 1997 ACR criteria for SLE were included. Late onset patients were >50 years of age and young onset were 18 years at the time of first SLE-related symptom. Clinical, laboratory, and autoantibody (ENA 25 & APLA) profiles were compared between the two groups using descriptive statistics and chi square test. Results: Of the 305 patients, 69 had late onset (75.4% females). Mean age was 59.42±6.7 years (Late onset lupus) and 33.13±8.44 years (young onset lupus). The most common symptom was arthritis (60%) followed by oral ulceration (50%), fever (43%), and serositis (37.68%). Most common antibody was SSA/Ro60 (50%) and anti-SSA/Ro52 (46%). Interstitial lung disease (ILD) (14.5%), pancytopenia (13%) and diffuse alveolar haemorrhage (4.3%) were more frequent in late onset group. Statistically significant differences were found between two groups in terms of photosensitivity (p=0.009), malar rash (p=0.005), excessive hair loss (p=0.0006), Raynaud’s phenomenon (p=0.001), lymphadenopathy (p=0.01), nephritis (p=0.0007), ILD (p=0.01), anti-dsDNA (p=0.005), anti-nucleosome (p=0.01), anti-Sm (p=0.007), Ribosomes P0 (p=0.0004). Conclusion: This study suggests that late onset SLE has distinct clinical and serological manifestations when compared with young onset SLE patients.

Cite this article as: Bindroo MA, Majid N, Ekbote G, Raval D, Negalur NV, Mendiratta N, Bajad S, Gupta R. Late Onset Systemic Lupus Erythematosus - Clinical and Autoantibody Profile and its Comparison with Young Onset Systemic Lupus Erythematosus. Mediterr J Rheumatol 2023;34(4):454-59

Article Submitted: 14 Nov 2022; Revised Form: 14 Jan 2023; Article Accepted: 26 Jan 2023; Available Online: 29 Jul 2023

This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).